Folinic acid (calcium folinate)
Brand names: Refolinon, Lederfolin
Folinic acid (calcium folinate) is a reduced folate used as rescue therapy after high-dose methotrexate and to counteract the toxicity of folate-antagonist drugs.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
As an already-reduced folate it bypasses the dihydrofolate reductase step blocked by methotrexate, restoring folate-dependent synthesis in normal cells and so limiting antifolate toxicity.
Prescribing in practice
- Folinic acid rescue must be given at the correct time and dose relative to methotrexate, because delayed or inadequate rescue can result in life-threatening methotrexate toxicity.
- It is used to treat overdose or accidental overexposure to folate-antagonist drugs and certain methotrexate-induced toxicities.
- It does not reverse the antifolate effect of trimethoprim-sulfamethoxazole on a treated infection in the way that simple folate supplementation would, and product-specific guidance should be followed.
Monitoring
In methotrexate rescue, monitor methotrexate plasma levels and renal function to determine the duration and intensity of folinic acid cover.
Counselling the patient
- This is a rescue medicine that protects healthy cells from chemotherapy toxicity.
- It must be taken exactly on schedule after methotrexate.
- Report mouth ulcers, vomiting or feeling very unwell after methotrexate treatment.
Evidence & guidelines
Folinic acid (calcium folinate) rescue is the established standard for limiting toxicity after high-dose methotrexate and in folate-antagonist overdose.
Reference: UKHCDO; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.